KraneShares Electric Vehicles and Future Mobility vs Revolution Medicines Inc. Common Stock — how do they compare? KraneShares Electric Vehicles and Future Mobility trades at $27.82 (market cap $72.36M), while Revolution Medicines Inc. Common Stock trades at $190.57 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 557.2× KraneShares Electric Vehicles and Future Mobility's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold KraneShares Electric Vehicles and Future Mobility for 46 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| KARS | RVMD | |
|---|---|---|
Market Cap | $72.36M | $40.32B |
Volume | 5,034 | 4,855,734 |
Sector | Sector/Thematic | Health |
52-Week High | $38.01 | $221.15 |
52-Week Low | $27.25 | $47.50 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | — | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →